← FDA DRUG APPROVALS

FDA ANDA · ANDA087687

SPIRONOLACTONE

Sponsor: ASCOT

APPLICATION
ANDA087687
TYPE
ANDA
LATEST ACTION
1983-08-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

SPIRONOLACTONEDiscontinued
SPIRONOLACTONE 25MG · TABLET · ORAL

Approval history

1983-08-15Manufacturing (CMC) · Supplement 1AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →